Literature DB >> 5865239

Formation of histiocyte rings in response to Cryptococcus neoformans infection.

S Schneerson-Porat, A Shahar, M Aronson.   

Abstract

Entities:  

Mesh:

Year:  1965        PMID: 5865239

Source DB:  PubMed          Journal:  J Reticuloendothel Soc        ISSN: 0033-6890


× No keyword cloud information.
  8 in total

1.  Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation.

Authors:  A Vecchiarelli; C Retini; C Monari; A Casadevall
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  The cellular responses of the rat to an intraperitoneal inoculation of Nippostrongylus brasiliensis larvae.

Authors:  Z Greenberg; G Wertheim
Journal:  Immunology       Date:  1973-03       Impact factor: 7.397

3.  Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.

Authors:  M Feldmesser; Y Kress; P Novikoff; A Casadevall
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 4.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

Review 5.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

6.  Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.

Authors:  T R Kozel; J L Follette
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

7.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

8.  CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract.

Authors:  J O Hill
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.